<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Gene Therapy: Treating disease by repairing genes</title>
  </titleInfo>
  <name type="personal">
    <namePart>Panno, Joseph.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">xxu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">New York</placeTerm>
    </place>
    <publisher>Fact On File</publisher>
    <dateIssued>2005</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xvii, 172p.: ills.; 23cm.</extent>
  </physicalDescription>
  <tableOfContents>Contents: Genetic  Disorders: Immune Deficiencies -- Breast Cancer -- Colon Cancer -- Melanoma -- Cystic Fibrosis -- Hemophilia -- Liver Disease -- Cardiovascular Disease -- Muscular Dystrophy -- Alzheimer's Disease -- Parkinson's Disease -- Huntington's  Disease -- Viruses: The Cornerstone of Gene Therapy: Viruses are Living Crystals Viral Genomes May be RNA or DNA -- Viruses Evolved from Plasmids -- Viruses know how to Infect Cells -- The Viruses as a Gene Vehicle -- Viruses Used in Gene Therapy -- Ashi Desilva: A Promising Start -- Clinical Trials Defined -- Cells of the Immune System -- Adenosine Deaminase(ADA) -- Preliminary Research -- Clinical Procedure for ADA Gene Therapy -- Jesse Gelsinger:Down To Earth: Ornithine Transcarbamylase(OTC) -- Preliminary Research -- Clinical Procedure for OTC Gene Therapy -- The Gelsinger Clinical Trial -- The Investigation -- Conclusion Remarks -- Future Prospects: Safer Vehicles -- Reduction Immune Rejection of the Vector -- Improved Risk Assessment -- Redesigning  Human Anatomy and Physiology -- Ethics of Gene Therapy -- The Belmont Report -- Clinical Trials -- Physiological Enhancement -- Cosmetic Applications -- Legal Issues: Rgulatory Agencies -- The Gelsinger Legal Trial -- International Regulation -- Resource Center -- Eukaryoke Cell Primer -- Recombinant DNA primer -- The Human Genome Project -- X- Linked Severe Combined Immunodeficiency (SCID-X1) Alzheimer,s Disease(AD) -- Huntingdon's Disease(HD).  </tableOfContents>
  <note type="statement of responsibility">Joseph Pano.</note>
  <note>Includes Index.</note>
  <classification authority="lcc">RB155.8.P36</classification>
  <identifier type="isbn">0816049483</identifier>
  <recordInfo>
    <recordCreationDate encoding="marc">180212</recordCreationDate>
  </recordInfo>
</mods>
